Potential eligibility for low dose rivaroxaban treatment in a "real world" population of Spanish patients with stable coronary artery disease: a subanalysis of the CICCOR registry

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Coronary Artery Disease (Chronic) ePosters Pharmacotherapy ESC Premium Access ESC Congress 2020

ESC 365 is supported by

ESC 365 is supported by